Literature DB >> 3314108

The pathogenesis of Rhodococcus equi pneumonia in foals.

J A Yager1.   

Abstract

The pathogenesis of Rhodococcus equi pneumonia in foals is reviewed. The main routes of infection are respiratory and alimentary. The latter is probably the chief route of exposure in all foals and probably leads to development of specific immunity. Susceptible foals, those whose maternal immunity wanes before generation of their own immune response, readily develop disease if exposed aerogenously to sufficient numbers of R. equi. Management and environmental circumstances have a major role to play in determining the magnitude of this challenge and, therefore, in the prevalence of the disease. Infection of a naive foal leads to severe, suppurative bronchopneumonia with suppurative lymphadenitis of regional nodes and, in approximately 50% of animals, to necrotizing enterocolitis. The foal is uniquely susceptible to R. equi pneumonia; comparable experimental infections do not produce progressive destructive pulmonary lesions in other animal species. In the naive foal lung, R. equi behaves as a facultative intracellular pathogen, avoiding destruction within the alveolar macrophage by inhibiting phagolysosome fusion and possibly by causing lysosomal degranulation. The role of putative virulence factors, such as equi factor, remains to be elucidated.

Entities:  

Mesh:

Year:  1987        PMID: 3314108     DOI: 10.1016/0378-1135(87)90109-x

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  24 in total

1.  The equine antimicrobial peptide eCATH1 is effective against the facultative intracellular pathogen Rhodococcus equi in mice.

Authors:  Margot Schlusselhuber; Riccardo Torelli; Cecilia Martini; Matthias Leippe; Vincent Cattoir; Roland Leclercq; Claire Laugier; Joachim Grötzinger; Maurizio Sanguinetti; Julien Cauchard
Journal:  Antimicrob Agents Chemother       Date:  2013-07-01       Impact factor: 5.191

2.  Pleural malakoplakia caused by Rhodococcus equi infection in a patient after stem cell transplantation.

Authors:  Carl Ludwig Behnes; Silke Neumann; Stefan Schweyer; Heinz-Joachim Radzun
Journal:  Diagn Pathol       Date:  2012-02-23       Impact factor: 2.644

3.  Identification of intermediately virulent Rhodococcus equi isolates from pigs.

Authors:  S Takai; N Fukunaga; S Ochiai; Y Imai; Y Sasaki; S Tsubaki; T Sekizaki
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

4.  Association between a large plasmid and 15- to 17-kilodalton antigens in virulent Rhodococcus equi.

Authors:  S Takai; T Sekizaki; T Ozawa; T Sugawara; Y Watanabe; S Tsubaki
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

5.  Purification and properties of cholesterol oxidase and choline phosphohydrolase from Rhodococcus equi.

Authors:  R S Machang'u; J F Prescott
Journal:  Can J Vet Res       Date:  1991-10       Impact factor: 1.310

6.  Virulence of Rhodococcus equi isolates from patients with and without AIDS.

Authors:  S Takai; Y Sasaki; T Ikeda; Y Uchida; S Tsubaki; T Sekizaki
Journal:  J Clin Microbiol       Date:  1994-02       Impact factor: 5.948

7.  Rhodococcus equi plasmids: isolation and partial characterization.

Authors:  O Tkachuk-Saad; J Prescott
Journal:  J Clin Microbiol       Date:  1991-12       Impact factor: 5.948

8.  Prevalence of virulent Rhodococcus equi in isolates from soil and feces of horses from horse-breeding farms with and without endemic infections.

Authors:  S Takai; S Ohbushi; K Koike; S Tsubaki; H Oishi; M Kamada
Journal:  J Clin Microbiol       Date:  1991-12       Impact factor: 5.948

9.  Virulence-associated plasmids in Rhodococcus equi.

Authors:  S Takai; Y Watanabe; T Ikeda; T Ozawa; S Matsukura; Y Tamada; S Tsubaki; T Sekizaki
Journal:  J Clin Microbiol       Date:  1993-07       Impact factor: 5.948

10.  Monoclonal antibody specific to virulence-associated 15- to 17-kilodalton antigens of Rhodococcus equi.

Authors:  S Takai; M Iie; C Kobayashi; T Morishita; T Nishio; T Ishida; T Fujimura; Y Sasaki; S Tsubaki
Journal:  J Clin Microbiol       Date:  1993-10       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.